Arrowhead Pharmaceuticals
ARWR
#1724
Rank
โ‚น1.206 T
Marketcap
โ‚น8,566
Share price
19.03%
Change (1 day)
562.73%
Change (1 year)

Revenue for Arrowhead Pharmaceuticals (ARWR)

Revenue in 2026 (TTM): โ‚น55.76 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น60.06 Billion. In 2025 the company made a revenue of โ‚น97.93 Billion an increase over the revenue in the year 2024 that were of โ‚น0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arrowhead Pharmaceuticals from 2000 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น55.76 B-43.06%
2025 โ‚น97.93 B45565.27%
2024 โ‚น0.21 B-98.58%
2023 โ‚น15.12 B-34.31%
2022 โ‚น23.03 B114.26%
2021 โ‚น10.74 B84.1%
2020 โ‚น5.83 B-49.95%
2019 โ‚น11.66 B252.8%
2018 โ‚น3.30 B69.51%
2017 โ‚น1.95 B540.77%
2016 โ‚น0.30 B1696.54%
2015 โ‚น16.94 M-11.46%
2014 โ‚น19.14 M77.04%
2013 โ‚น10.81 M-29.96%
2012 โ‚น15.43 M1118%
2011 โ‚น1.26 M-99.37%
2010 โ‚น0.20 B34.05%
2009 โ‚น0.14 B93.39%
2008 โ‚น77.24 M
2006 โ‚น15.68 M-51.17%
2005 โ‚น32.11 M
2002 โ‚น0.11 M-54.84%
2001 โ‚น0.26 M-77.46%
2000 โ‚น1.16 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.305 T 15,392.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
โ‚น212.84 B 254.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น26.50 B-55.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น18.62 B-69.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น413.99 B 589.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA